glp 1 clinical pearls 175: Live! Small Doses, Big Changes: Updates in Obesity Medicine with GLP-1s Clinical Pearls

There are many seemingly conflicting reports on the effects of Y1-R agonism versus antagonism found in the recent literature

Researchers used Truveta Data from over 40,000 patients to assess whether newer GLP-1 RA medications semaglutide and tirzepatide, commonly known by brand names Ozempic, Wegovy, Mounjaro, and Zepbound are associated with lower risks of emergency department visits and hospitalizations related to alcohol use

Experiment with all of them and see what works for you.

"It's a malfunction, basically, of our body's ability to compute energy balance." Individuals with obesity receive body signals telling them that they are hungrier, prompting them to find and consume more food to increase energy balance, Alexander added

West Virginia Medicaid covers Wegovy for obesity in addition to Ozempic and Mounjaro for type 2 diabetes